Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2016 Feb 23;32(9):878–884. doi: 10.1016/S1701-2163(16)34662-X

Antibiotic Prophylaxis in Obstetric Procedures

Julie van Schalkwyk 1,2, Nancy Van Eyk 1,2; INFECTIOUS DISEASES COMMITTEE,,,,,,,,,,,,1,2
PMCID: PMC7128122  PMID: 21050523

Abstract

Objective

To review the evidence and provide recommendations on antibiotic prophylaxis for obstetrical procedures.

Outcomes

Outcomes evaluated include need and effectiveness of antibiotics to prevent infections in obstetrical procedures.

Evidence

Published literature was retrieved through searches of Medline and The Cochrane Library on the topic of antibiotic prophylaxis in obstetrical procedures. Results were restricted to systematic reviews, randomized controlled trials/controlled clinical trials, and observational studies. Searches were updated on a regular basis and articles published from January 1978 to June 2009 were incorporated in the guideline. Current guidelines published by the American College of Obstetrics and Gynecology were also incorporated. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology assessment-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.

Values

The evidence obtained was reviewed and evaluated by the Infectious Diseases Committee of the Society of Obstetricians and Gynaecologists of Canada under the leadership of the principal authors, and recommendations were made according to guidelines developed by the Canadian Task Force on Preventive Health Care (Table 1).

Benefits, Harms, and Costs

Implementation of this guideline should reduce the cost and harm resulting from the administration of antibiotics when they are not required and the harm resulting from failure to administer antibiotics when they would be beneficial.

Summary Statements

  • 1.

    Available evidence does not support the use of prophylactic antibiotics to reduce infectious morbidity following operative vaginal delivery. (II-1)

  • 2.

    There is insufficient evidence to argue for or against the use of prophylactic antibiotics to reduce infectious morbidity for manual removal of the placenta. (III)

  • 3.

    There is insufficient evidence to argue for or against the use of prophylactic antibiotics at the time of postpartum dilatation and curettage for retained products of conception. (III)

  • 4.

    Available evidence does not support the use of prophylactic antibiotics to reduce infectious morbidity following elective or emergency cerclage. (II-3)

Recommendations

  • 1.

    All women undergoing elective or emergency Caesarean section should receive antibiotic prophylaxis. (I-A)

  • 2.

    The choice of antibiotic for Caesarean section should be a single dose of a first-generation cephalosporin. If the patient has a penicillin allergy, clindamycin or erythromycin can be used. (I-A)

  • 3.

    The timing of prophylactic antibiotics for Caesarean section should be 15 to 60 minutes prior to skin incision. No additional doses are recommended. (I-A)

  • 4.

    If an open abdominal procedure is lengthy (> 3 hours) or estimated blood loss is greater than 1500 mL, an additional dose of the prophylactic antibiotic may be given 3 to 4 hours after the initial dose. (III-L)

  • 5.

    Prophylactic antibiotics may be considered for the reduction of infectious morbidity associated with repair of third and fourth degree perineal injury. (I-B)

  • 6.

    In patients with morbid obesity (BMI > 35), doubling the antibiotic dose may be considered. (III-B)

  • 7.

    Antibiotics should not be administered solely to prevent endocarditis for patients who undergo an obstetrical procedure of any kind. (III-E

Key Words: Antibiotic prophylaxis, surgical prophylaxis, obstetrical procedures, surgical site infection, SSI, endometritis, endocarditis

Footnotes

This Clinical Practice Guideline has been prepared by the Infectious Diseases Committee and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.

Disclosure statements have been received from all members of the committee.

The literature searches and bibliographic support for this guideline were undertaken by Becky Skidmore, Medical Research Analyst, Society of Obstetricians and Gynaecologists of Canada.

This document reflects emerging clinical and scientific advances on the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Local institutions can dictate amendments to these opinions. They should be well documented if modified at the local level. None of these contents may be reproduced in any form without prior written permission of the SOGC.

Contributor Information

INFECTIOUS DISEASES COMMITTEE:

Mark H. Yudin, Marc Boucher, Beatrice Cormier, Andrée Gruslin, Deborah M. Money, Gina Ogilvie, Eliana Castillo, Caroline Paquet, Audrey Steenbeek, Nancy Van Eyk, Julie van Schalkwyk, and Thomas Wong

REFERENCES

  • 1.Zoutman D.E., Ford B.D. A comparison of infection control program resources, activities, and antibiotic resistant organism rates in Canadian acute care hospitals in 1999 and 2005: pre and post-severe acute respiratory syndrome. Am J Infect Control. 2008;36:711–717. doi: 10.1016/j.ajic.2008.02.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dancer S.J. How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy. Lancet Infect Dis. 2004;4:611–619. doi: 10.1016/S1473-3099(04)01145-4. [DOI] [PubMed] [Google Scholar]
  • 3.Huskins W.C., Ba-Thike K., Festin M.R., Limpongsanurak S., Lumbiganon P., Peedicayil A. Global Network for Perinatal and Reproductive Health. An international survey of practice variation in the use of antibiotic prophylaxis in cesarean section. Int J Gynaecol Obstet. 2001;73:141–145. doi: 10.1016/s0020-7292(01)00365-4. [DOI] [PubMed] [Google Scholar]
  • 4.Bratzler D.W., Houck P.M., Richards C., Steele L., Dellinger E.P., Fry D.E. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg. 2005;140:174–182. doi: 10.1001/archsurg.140.2.174. [DOI] [PubMed] [Google Scholar]
  • 5.American College of Obstetricians and Gynecologists ACOG practice bulleting number 47,October 2003. Prophylactic antibiotics in labor and delivery. Obstet Gynecol. 2003;102:875–882. doi: 10.1016/s0029-7844(03)00984-0. [DOI] [PubMed] [Google Scholar]
  • 6.Tanner J., Woodings D., Moncaster K. Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev. 2006;3 doi: 10.1002/14651858.CD004122.pub2. [DOI] [PubMed] [Google Scholar]
  • 7.Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27:97–134. [PubMed] [Google Scholar]
  • 8.Classen D.C., Evans R.S., Pestotnik S.L., Horn S.D., Menlove R.L., Burke J.P. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992;326(5):281–286. doi: 10.1056/NEJM199201303260501. [DOI] [PubMed] [Google Scholar]
  • 9.Bratzler D.W., Houck P.M. Surgical Infection Prevention Guidelines Writers Workgroup; American Academy of Orthopaedic Surgeons; American Association of Critical Care Nurses; American Association of Nurse Anesthetists; American College of Surgeons; American College of Osteopathic Surgeons; American Geriatrics Society; American Society of Anesthesiologists; American Society of Colon and Rectal Surgeons; American Society of Health-System Pharmacists; American Society of PeriAnesthesia Nurses; Ascension Health; Association of periOperative Registered Nurses; Association for Professionals in Infection Control and Epidemiology; Infectious Diseases Society of America; Medical Letter; Premier; Society for Healthcare Epidemiology of America; Society of Thoracic Surgeons; Surgical Infection Society. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38:1706–1715. doi: 10.1086/421095. [DOI] [PubMed] [Google Scholar]
  • 10.Dellinger E.P., Gross P.A., Barrett T.L., Krause P.J., Martone W.J., McGowan J.E., Jr. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis. 1994;18:422–427. doi: 10.1093/clinids/18.3.422. [DOI] [PubMed] [Google Scholar]
  • 11.Gibbs R.S. Clinical risk factors for puerperal infection. Obstet Gynecol. 1980;55(Suppl 5):18S–184S. doi: 10.1097/00006250-198003001-00045. [DOI] [PubMed] [Google Scholar]
  • 12.Henderson E., Love E.J. Incidence of hospital-acquired infections associated with caesarean section. J Hosp Infect. 1995;29:245–255. doi: 10.1016/0195-6701(95)90271-6. [DOI] [PubMed] [Google Scholar]
  • 13.Lee T.B., Baker O.G. Forum: surveillance of surgical site infections. Asepsis. 1994;167–211 [PubMed] [Google Scholar]
  • 14.Opoein H.K., Valbo A., Grinde-Andersen Q., Qalberg M. Post-cesarean surgical site infections according to CDC standards: rates and risk factors. A prospective cohort study. Act Obstet Gynecol Scand. 2007;86:1097–1102. doi: 10.1080/00016340701515225. [DOI] [PubMed] [Google Scholar]
  • 15.Smaill F., Hofmeyr G.J. Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev. 2002;3 doi: 10.1002/14651858.CD000933. [DOI] [PubMed] [Google Scholar]
  • 16.Chelmow D., Ruehli M.S., Huang E. Prophylactic use of antibiotics for nonlaboring patients undergoing cesarean delivery with intact membranes: a meta-analysis. Am J Obstet Gynecol. 2001;184:656–661. doi: 10.1067/mob.2001.111303. [DOI] [PubMed] [Google Scholar]
  • 17.Sullivan S.A., Smith T., Chang E., Hulsey T., Vandorsten J.P., Soper D. Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing postcesarean infectious morbidity: a randomized, controlled trial. Am J Obstet Gynecol. 2007;196:e1–e5. doi: 10.1016/j.ajog.2007.03.022. [DOI] [PubMed] [Google Scholar]
  • 18.Costantine M.M., Rahman M., Ghulmiyah L., Byers B.D., Longo M. Wen T, et Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol. 2008;199(3):e1–e6. doi: 10.1016/j.ajog.2008.06.077. [DOI] [PubMed] [Google Scholar]
  • 19.Gordon S.M. Antibiotic prophylaxis against postoperative wound infection. Cleve Clin J Med. 2006;73(Suppl 1):42–45. doi: 10.3949/ccjm.73.suppl_1.s42. [DOI] [PubMed] [Google Scholar]
  • 20.Tita A.T., Rouse D.J., Blackwell S., Saade G.R., Spong C.Y., Andrews W.W. Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol. 2009;113:675–682. doi: 10.1097/AOG.0b013e318197c3b6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Liabsuetrakul T., Choobun T., Peeyananjarassri K., Islam M. Antibiotic prophylaxis for operative vaginal delivery. Cochrane Database Syst Rev. 2004;3 doi: 10.1002/14651858.CD004455.pub2. [DOI] [PubMed] [Google Scholar]
  • 22.Chongsomchai C., Lumbiaganon P., Laopaiboon M. Prophylactic antibiotic for manual removal of retained placenta in vaginal delivery. Cochrane Database Syst Rev. 2006;2 doi: 10.1002/14651858.CD004904.pub2. [DOI] [PubMed] [Google Scholar]
  • 23.World Health Organisation (WHO) WHO guidelines for the managemen of postpartum hemorrhage and retained placenta. WHO; Geneva: 2009. http://whqlibdoc.who.int/publications/2009/9789241598514_eng.pdf Available at, Accessed May 23, 2010. [Google Scholar]
  • 24.Turrentine M.A., Banks T.A. Effect of changing gloves before placental extraction on incidence of postcesarean endometritis. Infect Dis Obstet Gynecol. 1996;4:16–19. doi: 10.1155/S106474499600004X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lasley D.S., Eblen A., Yancey M.K., Duff P. The effect of placental removal method on the incidence of postcesarean infections. Am J Obstet Gyneco. 1997;176:1250–1254. doi: 10.1016/s0002-9378(97)70342-9. [DOI] [PubMed] [Google Scholar]
  • 26.Buppasiri P., Lumbiganon P., Thinkhamrop J., Thinkhamrop B. Antibiotic prophylaxis for fourth degree perineal tear during vaginal birth. Cochrane Database Syst Rev. 2005;4 doi: 10.1002/14651858.CD005125.pub2. [DOI] [PubMed] [Google Scholar]
  • 27.Duggal N., Mercado C., Daniels K., Bujor A., Caughey A.B., El-Sayed Y.Y. Antibiotic prophylaxis for prevention of postpartum perineal wound complications: a randomized controlled trial. Obstet Gynecol. 2008;111:1268–1273. doi: 10.1097/AOG.0b013e31816de8ad. [DOI] [PubMed] [Google Scholar]
  • 28.Shiffman R.L. Continuous low-dose antibiotics and cerclage for recurrent second-trimester pregnancy loss. J Reprod Med. 2000;45:323–326. [PubMed] [Google Scholar]
  • 29.Terkildsen M.F., Parilla B.V., Kumar P., Grobman W.A. Factors associated with success of emergent second-trimester cerclage. Obstet Gynecol. 2003;101:565–569. doi: 10.1016/s0029-7844(02)03117-4. [DOI] [PubMed] [Google Scholar]
  • 30.Heslehurst N., Simpson H., Ells L.J., Rankin J., Wilkinson J., Lang R. The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev. 2008;9635–9683 doi: 10.1111/j.1467-789X.2008.00511.x. [DOI] [PubMed] [Google Scholar]
  • 31.Lee C.E., Zembower T.R., Fotis M.A., Postelnick M.J., Greenberger P.A., Peterson L.R. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med. 2000;160:2819–2822. doi: 10.1001/archinte.160.18.2819. [DOI] [PubMed] [Google Scholar]
  • 32.Sogn D.D., Evans R., 3rd, Shepherd G.M., Casale T.B., Condemi J., Greenberger P.A. Results of the National Institute of Allergy and Infectious Diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med. 1992;152:1025. [PubMed] [Google Scholar]
  • 33.del Real G.A., Rose M.E., Ramirez-Atamoros M.T., Hammel J., Gordon S.M., Arroliga A.C., Arroliga M.E. Penicillin skin testing in patients with a history of beta-lactam allergy. Ann Allergy Asthma Immunol. 2007;98:355–359. doi: 10.1016/S1081-1206(10)60882-4. [DOI] [PubMed] [Google Scholar]
  • 34.International Rheumatic Fever Study Group Allergic reactions to long-term benzathine penicillin propylaxis for rheumatic fever. Lancet. 1991;337(8753):1308–1310. [PubMed] [Google Scholar]
  • 35.Dash C.H. Penicillin allergy and the cephalosporins. J Antimicrob Chemother. 1975;1:107. doi: 10.1093/jac/1.suppl_3.107. [DOI] [PubMed] [Google Scholar]
  • 36.Daulat S., Solensky R., Earl H.S., Casey W., Gruchalla R.S. Safety of cephalosporin administration to patients with histories of penicillin allergy. J Allergy Clin Immunol. 2004;113:1220. doi: 10.1016/j.jaci.2004.03.023. [DOI] [PubMed] [Google Scholar]
  • 37.Fonacier L., Hirschberg R., Gerson S. Adverse drug reactions to a cephalosporins in hospitalized patients with a history of penicillin allergy. Allergy Asthma Proc. 2005;26:135. [PubMed] [Google Scholar]
  • 38.Wilson W., Taubert K.A., Gewitz M., Lockhart P.B., Baddour L.M., Levison M. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of Infective Endocarditis: Guidelines From the American Heart Association. Circulation. 2007;116:1736–1754. doi: 10.1161/CIRCULATIONAHA.106.183095. [DOI] [PubMed] [Google Scholar]
  • 39.Castillo E., Magee L.A., von Dadelszen P., Money D., Blondel-Hill E., van Schalkwyk J. Our patients do not need endocarditis prophylaxis for genitourinary tract prodecures: insights from the 2007 Amercian Heart Association guidelines. J Obstet Gynaecol Can. 2008;30:796–799. doi: 10.1016/S1701-2163(16)32944-9. [DOI] [PubMed] [Google Scholar]
  • 40.Woolf S.H., Battista R.N., Angerson G.M., Logan A.G., Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ. 2003;169:207–208. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Obstetrics and Gynaecology Canada are provided here courtesy of Elsevier

RESOURCES